Yang Yang

the first people’s hospital of guiyang

H指数:27

被引数:2,473

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

α-Hederin Alleviates Endoplasmic Reticulum Stress by Upregulating TRIM38 Expression, Thereby Inhibiting Hepatic Stellate Cell Activation and Liver Fibrosis

α-Hederin通过上调TRIM38表达缓解内质网应激，从而抑制肝星状细胞活化和肝纤维化。

Biomedicines

IF3.9

2026-04-050

Cutaneous metastasis secondary to nasopharyngeal carcinoma: a case report

鼻咽癌继发性皮肤转移：一例病例报告

World Journal of Surgical Oncology

IF2.5

2025-11-220

OAAI

Stroma-specific IL-15 coordinates epithelial IL-15Rα to promote intestinal epithelial repair

基质特异性的IL-15协调上皮IL-15Rα以促进肠道上皮修复

Science China Life Sciences

IF9.5

2025-10-140

PRE

Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain (vol 12, 85, 2023)

嵌合抗原受体T细胞移植PD1外膜域的靶向性和细胞毒性（卷12，85，2023）

hematology oncology

IF13.5

2025-04-020

Immunoglobulin-like transcript 5 polarizes M2-like tumor-associated macrophages for immunosuppression in non-small cell lung cancer

免疫球蛋白样转录本5极化M2-like肿瘤相关巨噬细胞在非小细胞肺癌中的免疫抑制作用

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-02-050

Cistanche deserticola polysaccharide-functionalized dendritic fibrous nano-silica as oral delivery system for H9N2 vaccine to promote systemic and mucosal immune response

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-12-010

PRE

Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fl udarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma

CYTOTHERAPY

IF3.2

2024-05-011

OAAI

Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma

CELLULAR ONCOLOGY

IF4.8

2024-04-025

PRE

Cistanche deserticola polysaccharide-functionalized dendritic fibrous nano-silica as oral vaccine adjuvant delivery enhancing both the mucosal and systemic immunity

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-03-017

PRE

IL-7 promotes CD19-directed CAR-T cells proliferation through miRNA-98-5p by targeting CDKN1A

IL-7通过靶向CDKN1A通过miRNA-98-5p促进CD19-directed car-t细胞增殖

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-11-011

OAAI

Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain

PD1膜外结构域移植的嵌合抗原受体T细胞的靶向性和细胞毒性

hematology oncology

IF13.5

2023-09-302

OAAI

Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-04-201

OAAI

Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study

THERAPEUTIC ADVANCES IN HEMATOLOGY

IF3.1

2023-01-125

OAAI

MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-11-0114

OAAI

Pickering emulsion stabilized by Chinese Yam polysaccharides PLGA for enhanced humoral and cellular immune responses

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2022-10-016

PRE

Chinese yam polysaccharides PLGA-stabilized Pickering emulsion as an adjuvant system for PCV-2 vaccine to enhance immune response

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2022-10-0115

PRE

First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience

rATG和CsA一线免疫抑制治疗重度再生障碍性贫血: 15年经验

ANNALS OF HEMATOLOGY

IF2.4

2022-09-246

PRE

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-0426

OAAI

Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-124

OAAI

Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19

SCIENCE BULLETIN

IF21.1

2022-05-017

OAAI

Yang Yang

个人简介

教育背景

工作经历

荣誉奖项

研究方向